Drug Profile
RG 7103
Alternative Names: R 7103; RG7103; RO5024118Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Roche
- Class Antiasthmatics; Small molecules
- Mechanism of Action Vasoactive intestinal peptide type II receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 01 Oct 2016 Roche withdraws a phase I trial prior to enrollment for Chronic obstructive pulmonary disease in USA (Inhalation) (NCT01009424)
- 27 Oct 2009 Phase-I development is ongoing